HUTCHMED divested a 45.0% equity interest in SHPL for $608.5 million in cash in April 2025, retaining a 5.0% equity interest. As a result, HUTCHMED’s share of equity in earnings of SHPL in 2025 ...

They are experts in a parasitic amoeba, scientific history, the health effects of stress and more, and now these eight faculty members can add a new title: Chancellor’s Fellow.The recognition is given ...

A new NASA analysis concludes that it is "reasonable to hypothesize" that living things could have formed the odd organic ...

Northwell's Dr. Dan King co-developed the iNav tool.

As reported in December 2025, data from the aleniglipron clinical program included 36-week data from the core Phase 2b ACCESS study and the exploratory ACCESS II study, as well as interim data from ...

Thank you for being here this morning. I’m Dan Felton, President and CEO of the Flexible Packaging Association (FPA). I’ll spend about 20 to 25 minutes sharing information about FPA, the flexible ...

Integrating AI with advanced robotics to create self-driving labs (SDL) is a promising approach to tackling molecular discovery.

The fireside chats will be webcast live and may be accessed through Relay Therapeutics’ website under Events in the News & Events section through the following link: https://ir.relaytx.com/news-events ...

A small but mighty piece of lab equipment, about the size of a cellphone, has arrived at the International Space Station after launching with NASA's SpaceX Crew-12 mission. NASA aims to use the ...

UVA Comprehensive Cancer Center scientists have identified a molecule that blocks the gene responsible for glioblastoma, raising hopes that the molecule could become a much-needed new treatment for ...

QIMR Berghofer scientists have discovered a cancer-fighting RNA molecule that could hold the key to a new way of treating the most common form of breast cancer. The team are developing their findings ...